• Those Who Purchased Basilea Pharmaceutica (VTX:BSLN) Shares Five Years Ago Have A 45% Loss To Show For It

    It is a pleasure to report that the Basilea Pharmaceutica AG (VTX:BSLN) is up 43% in the last quarter. But that...


  • JPMorgan Says Short U.S. 30-Year Bond on Excess Haven Demand

    (Bloomberg) -- JPMorgan Chase & Co. strategists are betting that the surge in demand for Treasuries thanks to fears about the deadly coronavirus will prove short-lived, sticking with a call to sell longer-dated bonds.Among the Wall Street bank’s other takeaways from their latest market-outlook reports: the outbreak of the disease is a “clear negative” for emerging Asian currencies, while for stocks it could be a buying opportunity if historical parallels hold.“This is the latest risk of a series that have driven U.S. Treasury yields far below what fundamentals indicate,” strategists including Matthew Jozoff wrote in a note Friday. “We don’t intend to be dismissive of the coronavirus, as it is a serious concern both in human and economic turns,” they wrote, while flagging that JPMorgan analysis notes a trend toward reduced mortality in health epidemics over time.Geopolitical tensions stemming from Iran spurred a rally in Treasuries earlier this month, before the coronavirus emerged as a new threat to global economic growth. The bond bid extended on Monday, with 10-year U.S. yields sliding as low as 1.62%, the lowest since October.That latest leg down came after JPMorgan strategists had calculated that yields were almost 30 basis points “too low” compared with expectations for growth, inflation and Federal Reserve policy decisions, along with gauges of investor positioning and the share of negative-yielding debt in developed markets.“Ten-year Treasuries have not been this dislocated on this basis since a brief period in the spring of 2015,” JPMorgan calculated. “We remain short 30-year U.S. Treasuries.”‘Buying Opportunities’Turning to stocks, JPMorgan’s equity strategists flagged that the health-scare could lead to more near-term declines, while concluding that “past pandemics episodes didn’t lead to sustained selling, they tended to ultimately be buying opportunities.”On the currency side, JPMorgan shifted its emerging Asia position to neutral, thanks to closing its overweight recommendation on Malaysia’s ringgit, which on Friday snapped a four-week winning streak.“Such outbreaks can subside as quickly as they have emerged,” JPMorgan currency strategists led by Paul Meggyesi wrote. “However, previous episodes show that risk appetite can be disrupted for at least a number of weeks, particularly from an FX standpoint.”(Adds comments on stocks and currencies starting in second paragraph.)To contact the reporter on this story: Christopher Anstey in Tokyo at canstey@bloomberg.netTo contact the editors responsible for this story: Chris Nagi at chrisnagi@bloomberg.net, Cormac Mullen, Ravil ShirodkarFor more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2020 Bloomberg L.P.


  • Don't Sell China East Education Holdings Limited (HKG:667) Before You Read This

    The goal of this article is to teach you how to use price to earnings ratios (P/E ratios). To keep it practical, we'll...


  • Those Who Purchased Endomines (STO:ENDO) Shares Five Years Ago Have A 88% Loss To Show For It

    Endomines AB (publ) (STO:ENDO) shareholders should be happy to see the share price up 16% in the last month. But that...


  • Arix Co-founds Quench Bio With Series A Financing

    Arix Bioscience plc ("Arix", LSE: ARIX) a global venture capital company focused on investing in and building breakthrough biotech companies, today announces that its discovery portfolio company Quench Bio has emerged from stealth mode with the completion of a Series A financing. This follows a period of company creation, with seed investment and close involvement by Arix.


  • Finastra Strengthens Its Position in Israel With New Office Opening

    Finastra is investing further in Israel with a new office in Kfar Saba, just outside Tel Aviv. The office, which is home to over 330 employees, offers more space for the Finastra team to grow as the company strengthens its position in the country, and provides an ultra-modern workspace to inspire creativity and facilitate collaboration. The move will help the company support technological and financial innovation in the region, and drive adoption of its open development platform, FusionFabric.cloud.


  • Reiss Holdings Limited reports strong like-for-like sales over the Christmas period and continues to expand its global footprint

    Reiss Holdings Limited, the premium international fashion brand, today reported Christmas trading figures for 7 weeks to 18th January 2020.


  • Quench Bio Closes $50M Series A Financing to Advance First-in-Class Medicines Targeting Gasdermin to Treat Severe Inflammatory Diseases

    Quench Bio, a company leveraging new insights into gasdermin biology and innate immunology to develop medicines for severe inflammatory diseases, today announced the completion of a $50 million Series A financing led by RA Capital Management ("RA Capital"), with participation from new Investor Abbvie Ventures. Atlas Venture ("Atlas") and Arix Bioscience plc ("Arix", LSE: ARIX) who co-founded and seeded the company, also participated in the Series A. Quench Bio has incubated at Atlas since inception.


  • Crowe Global Reports Eight Years of Consecutive Growth

    Crowe Global (Crowe) reports an outstanding eight years of consecutive growth. The eighth largest audit, tax and advisory network in the world announced global revenues of US$4.4.bn in 2019, an increase of 3.5% (excluding Forex impact).


  • Industry Leaders Back new Specialist led Investment Company for Technology Start-ups

    Bloc Ventures Limited (Bloc), the venture capital company focussed on early stage European deep technology investment, today announces it has raised over £20m in equity funding from UK industry leaders.


(ARA) - Tax season is in full swing. Taxpayers receiving a refund tend to file earlier in the year, while those who owe Uncle Sam often wait until closer to the filing deadline. Whether you file now or wait until the last minute, make tax time easier with these tips.

Start by collecting all your tax documents and information, including W-2s, 1098s, 1099s, receipts and a copy of last year's return. Worried about forgetting something? Use a tax return checklist like the one offered at www.taxact.com/checklist.

Take a few minutes to get familiar with key tax law changes and expiring tax breaks. Notable changes this year include an increase in the standard deduction and standard mileage rates, and an end to the Making Work Pay Credit. A great place to start is by reading the one-page section called "What's New for 2011" in IRS Publication 17 at www.irs.gov.

Do your own taxes using an online or downloadable tax preparation solution. Products are designed for both tax experts and novices, guiding you step by step through your entire return, as well as your credits and deductions. The programs do the math, complete the forms and identify possible errors for you. If you need help from a tax expert, top solutions provide easy, in some cases free, answers.

Although these easy-to-use solutions do the hard work for you, remember they can't necessarily catch your data entry errors. Common errors include incorrect Social Security numbers, misspelled last names, and incorrect bank account numbers for direct deposit. Spend an extra minute or two checking this information to avoid rejection of your return.

It's common to spend upwards of $50 for a tax preparation solution, but there are quality free solutions. Compare free products carefully, as there are important differences. Many experts consider TaxACT to be the most complete free federal product, as it includes all e-fileable forms, free e-file, and free tax help. If you're changing solutions or filing for the first time, TaxACT in particular makes your experience easier with data import and fast start options. You can usually try online products risk-free, so you may find it worthwhile to take a couple for a test drive.

Electronically file your return. More than 100 million taxpayers chose this easy, convenient, and safe way to submit their federal returns last year. E-filed returns are processed faster than paper returns, and e-filers receive confirmation when their returns are processed, usually within minutes. If you owe taxes, you can e-file at any time and schedule payment via electronic funds withdrawal or credit card up until the filing deadline. Most states encourage e-filed returns.

If you're among the three out of four Americans who receive a refund from the IRS, e-file and select direct deposit for the fastest receipt. Your refund can be deposited directly into up to three accounts in as few as eight days (instead of six to eight weeks for mailed checks).

The deadline for filing tax year 2011 federal and most state income tax returns is Tuesday, April 17, 2012. Although you have a couple extra days to file, don't wait until the last minute. Rushing can result in data entry errors, and carefully reviewing tax credit and deduction information could end up saving you money. If you've experienced major life changes over the last year, allot extra time to make sure you get all your tax benefits.

If you need more time to file, simply file IRS Form 4868 for an automatic six-month extension to file. Keep in mind an extension does not extend your time to pay, so pay as much as possible by April 17. Filing late will land you a 5 percent per month penalty, up to a maximum for 25 percent of the unpaid balance, and the failure-to-pay penalty is 0.5 percent per month. Call the IRS to discuss payment plans and options if you can't pay your bill in full.

More tax tips and information can be found at www.irs.gov. To learn more about TaxACT and its Free Federal Edition, visit www.taxact.com.Tips for making tax time easier
Category: Business